Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-27
DOI
10.1038/s41467-020-19932-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CXCR4-targeted PET imaging using 64Cu-AMD3100 for detection of Waldenström Macroglobulinemia
- (2019) Barbara Muz et al. CANCER BIOLOGY & THERAPY
- Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy
- (2019) Micah John Luderer et al. PHARMACEUTICAL RESEARCH
- Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma
- (2018) Pilar de la Puente et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma
- (2017) Pilar de la Puente et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The next generation of novel therapies for the management of relapsed multiple myeloma
- (2017) Wilson I Gonsalves et al. Future Oncology
- Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome
- (2017) Shiran Ferber et al. eLife
- Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy
- (2016) W I Gonsalves et al. BONE MARROW TRANSPLANTATION
- P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
- (2016) Y. Shamay et al. Science Translational Medicine
- 3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma
- (2015) Pilar de la Puente et al. BIOMATERIALS
- Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib
- (2015) Barbara Muz et al. Biomed Research International
- Carfilzomib: A Second-Generation Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma
- (2013) Jennifer L Thompson ANNALS OF PHARMACOTHERAPY
- Bone Marrow Microenvironment in Multiple Myeloma Progression
- (2012) S. Manier et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment
- (2011) A. K. Azab et al. BLOOD
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Increased Liver Uptake and Reduced Hepatic Stellate Cell Activation with a Cell-Specific Conjugate of the Rho-kinase Inhibitor Y27632
- (2011) Marike Marjolijn van Beuge et al. PHARMACEUTICAL RESEARCH
- Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition
- (2010) Daisuke Tamura et al. CANCER SCIENCE
- Translating cancer research into targeted therapeutics
- (2010) J. S. de Bono et al. NATURE
- Pharmacokinetics and Pharmacodynamics of Plerixafor in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma
- (2009) Douglas A. Stewart et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma
- (2009) A. K. Azab et al. BLOOD
- Response: Sensitization initiated
- (2009) A. K. Azab et al. BLOOD
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy
- (2009) Paul G. Richardson et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search